Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-01-07 @ 6:16 AM
Study NCT ID:
NCT01830595
Status:
COMPLETED
Last Update Posted:
2024-12-31
First Post:
2013-04-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lactoferrin Treatment in HIV Patients
Sponsor:
Jason Baker
Organization:
Study Overview
Official Title:
Recombinant Lactoferrin to Reduce Immune Activation and Coagulation Among HIV Positive Patients
Status:
COMPLETED
Status Verified Date:
2024-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our general goal is to evaluate the potential effectiveness of recombinant lactoferrin (1500mg bid) for reducing inflammation among HIV positive participants.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: